Vital Signs Podcast: Breakthrough brain scanning technology overcoming diagnostic hurdles

Vital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist Nadine McGrath.

In this episode Nadine chats to Gordon Haid, the Global Neuro-Imaging Business Director of Compumedics (ASX:CMP), a medical device company focused on diagnostic tech for sleep, brain and blood flow monitoring.

Founded in 1987, Compumedics’ strategy was initially focused on developing its core competency, Sleep Diagnostics.

The company even set up Australia’s first ever fully computerised sleep clinic.

Today, Compumedics has evolved into one of the world’s leading suppliers of medical technology for sleep, neuro diagnostics and ultrasonic blood flow monitoring, with products distributed to clients around the globe, helping millions of people who suffer from debilitating sleep, neurological and other healthcare problems.

This podcast was developed in collaboration with Compumedics, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.